• Sengupta K, Thygesen LC, Kristiansen IS, Bolin K, Pukkala E, Emneus M, et al. Utilization of etoricoxib in dental patients in the Nordic countries: a population-based register study. Acta Odontologica Scandinavica. 2019:1-8. DOI: 10.1080/00016357.2019.1622037.
  • Komkova A, Brandt CJ, Hansen Pedersen D, Emneus M, Sortso C. Electronic Health Lifestyle Coaching Among Diabetes Patients in a Real-Life Municipality Setting: Observational Study. JMIR Diabetes. 2019;4(1):e12140. DOI: 10.2196/12140.
  • Kjaerulff TM, Ersboll AK, Green A, Emneus M, Brasso K, Iversen P, et al. Finasteride Use and Risk of Male Breast Cancer: A Case-Control Study Using Individual-Level Registry Data from Denmark, Finland, and Sweden. Cancer Epidemiology, Biomarkers & Prevention. 2019. DOI: 10.1158/1055-9965.Epi-18-0904.
  • Emneus M, Green A, Sortsø C, Sørup Yssing C, Zeeberg Steenstrup N, Fast T & Komkova A: “Pnd36 – Costs Of Multiple Sclerosis In Denmark: A Register Based Study”. Value in Health, 21, S335, 2018. DOI: https://doi.org/10.1016/j.jval.2018.09.2003 
  • Sortsø C, Komkova A, Sandbæk A, Griffin SJ, Emneus M, Lauritzen T, Simmons RK: “Effect of screening for type 2 diabetes on healthcare costs: a register-based study among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009”. Diabetologia, 61(6), 1306-1314, 2018. https://doi.org/10.1007/s00125-018-4594-2
  • Sortsø C, Lauridsen J, Emneus M, Green A, Jensen PB: “Social inequality in diabetes patients’ morbidity patterns from diagnosis to death – A Danish register-based investigation”. Scandinavian Journal of Public Health, 46(1), 2018: 92-101, 2018. DOI: 10.1177/1403494817713648 
  • Meijer M, Thygesen LC, Green A, Emneus M, Brasso K, Iversen P, Pukkala E, Bolin K, Stavem K, Ersbøll AK: “Finasteride treatment and male breast cancer: A register-based cohort study in four Nordic countries”. Cancer Medicine 7(1): 254-260, 2018. DOI: 10.1002/cam4.1273
  • ApEHR. LIVA Healthcare 2017 Cost-Effectiveness Analysis.2017 URL: https://livahealthcare.com/wp-content/uploads/2018/11/Report_Apehr_2017.pdf
  • Duvnjak S, Ravn P, Green A, Andersen PE: “Assessment of uterine fibroid infarction after embolization with tris-acryl gelatin microspheres”. Cogent Medicine 4, 2017: (Epub 28 July 2017). DOI: 10.1080/2331205X.2017.1360543
  • Duvnjak S, Ravn P, Green A, Andersen PE: “Magnetic resonance signal intensity ratio measurement before uterine artery embolization: Ability to predict fibroid size reduction”. Cardiovasc Intervent Radiol 40: 1839-1844, 2017. (Epub 8 June 2017). DOI: 10.1007/s00270-017-1721-2
  • Sortsø C, Lauridsen J, Emneus M, Green A, Jensen PB: “Social inequality in diabetes patients’ morbidity patterns from diagnosis to death – A Danish register based investigation”. Scand J Public Health, 1-10, 2017 (Epub 1 June 2017) DOI: 10.1177/1403494817713648
  • Dyrvig AK, Yderstræde KB, Gerke O, Jensen PB, Hess S, Høilund-Carlsen PF, Green A: “Cancer of unknown primary: registered procedures compared with national integrated cancer pathway for illuminating external validity”. Medicine 96:16(e6693), 2017. (Epub maj 2017). DOI: 10.1097/MD.0000000000006693
  • Iachina M, Jakobsen E, Fallesen AK, Green A: “Transfer between hospitals as a predictor of delay in diagnosis and treatment of patients with Non-Small Cell Lung Cancer – a register based cohort-study”. BMC Health Serv Res 17: 267, 2017.  (Epub 12 April 2017). DOI: 10.1186/s12913-017-2230-3
  • Iachina M, Brønserud MM, Jakobsen E, Trosko O, Green A: “History of depression in lung cancer: Impact of delay”. Clinical Oncol (R Coll Radiol) 9: 585-592, 2017. (Epub 13 April 2017). DOI: 10.1016/j.clon.2017.03.014
  • Sortsø C, Lauridsen J, Emneus M, Green A, Jensen PB: “Socioeconomics inequality of diabetes patients’ health care utilization in Denmark”. Health Econ Rev 7: 21, 2017.  (Epub 26 May 2017). DOI: 10.1186/s13561-017-0155-5
  • Brink M, Green A, Bojesen AB, Lamberti JS, Conwell Y, Andersen K: “Physical health, medication, and healthcare utilization among 70-year-old people with schizophrenia: A nationwide Danish Register Study. Am J Geriatr Psychiatry 25: 500-509, 2017. (Epub 9 January 2017). DOI: 10.1016/j.jagp.2016.12.015
  • Blindbæk SL, Schlosser A, Green A, Sørensen G, Grauslund J: “Association between microfibrillar-associated protein 4 (MFAP4) and micro- and macrovascular complications in long-term Type 1 diabetes mellitus”. Acta Diabetol 54: 367-72, 2017. DOI: 10.1007/s00592-016-0953-y
  • Duvnjak S, Ravn P, Green A, Andersen PE: “Uterine fibroid embolization with acrylamide polyvinyl microspheres: prospective 12-month clinical and MRI follow-up study”. Acta Radiol 58: 952-958, 2017. (Epub 21 November 2016). DOI:10.1177/0284185116679458
  • Mygind, L, Kryger, TB, Sidenius, G, Schipperijn, J & Bentsen, P 2017, “A school excursion to a museum can promote physical activity in children by integrating movement into curricular activities” European Physical Education Review, s. 1356336X17700660. DOI: 10.1177/1356336X17700660
  • ApEHR, the Danish Multidisciplinary Cancer Groups (DMCG.dk) & the Danish Clinical Registries (RKKP, Regionernes Kliniske Kvalitetsudviklingsprogram): Benchmarking II Report
  • Hollins, O., Lee, P., Sims, E., Bertham, O., Symington, H., Bell, N., Pfaltzgraff, L. and Sjögren, P. (2017). Towards a circular economy – Waste management in the EU. [online] STOA. Available at: http://www.europarl.europa.eu/RegData/etudes/STUD/2017/581913/EPRS_STU%282017%29581913_EN.pdf [Accessed 30 Oct. 2018].
  • Bolin K, Berggren F, Berling P, Morberg S, Gauffin H, Landtblom A-M. Patterns of antiepileptic drug prescription in Sweden: A register-based approach. Acta Neurologica Scandinavica. 2017 Nov;136(5):521–7. DOI: 10.1111/ane.12776.
  • Green A, Hauge J, Iachina M, Jakobsen E: “The mortality after surgery in primary lung cancer: results from the Danish Lung Cancer Registry”. Eur J CardioThoracic Surg 49: 589-594, 2016. (Epub 30 March 2015). DOI: 10.1093/ejcts/ezv107
  • Sortsø C, Green A, Jensen PB, Emneus M:”Societal costs of diabetes mellitus in Denmark”. Diabetic Medicine 33: 877-885, 2016. DOI: 10.1111/dme.12965. (Epub ahead of publication 29 October 2015)
  • Kjeldsen A, Agaard KS, Tørring PM, Möller S, Green A: “20-year follow-up study of Danish HHT patients – survival and causes of death”. Orphanet J Rare Dis 11: 157, 2016. (Epub 27. Nov 2016).  DOI: 10.1186/s13023-016-0533
  • Engberg H, Wehberg S, Bistrup C, Heaf J, Sørensen SS, Thiesson HC, Hansen JM, Svensson M, Green A, Marckmann P: “Cancer risk and mortality after kidney transplantation: a population-based study on differences between Danish centres using standard immunosuppression with and without glucocorticoids”. Nephrol Dial Transplant 31: 2149-56, 2016.  (Epub 8. September 2016). DOI: 10.1093/ndt/gfw304
  • Poulsen CD, Peto T, Grauslund J, Green A: “Epidemiologic characteristics of retinal detachment surgery at a specialized unit in Denmark”. Acta Ophthalmol 94: 548-555, 2016. (Epub 31. Marts 2016).  DOI: 10.1111/aos.13113
  • Jakobsen E, Rasmussen TR, Green A: “Survival of lung cancer in Denmark: Results from the Danish Lung Cancer Group 2000-2012” Acta Oncologica 55 Supp 2: 2-9, 2016. (Epub 8. April 2016). DOI: 10.3109/0284186X.2016.1150608
  • Iversen LH, Green A, Ingeholm P, Østerlind K, Gögenur I: “Improved survival of colorectal cancer in Denmark during 2001-2012 – the efforts of several national initiatives”. Acta Oncologica 55 Supp 2: 10-23, 2016. (Epub 9. Februar 2016). DOI: 10.3109/0284186X.2015.1131331
  • Jørgensen TMM, Christensen K, Lindholt JS, Larsen LA, Green A, Houlind K: “High heritability of liability to abdominal aortic aneurysms: A population based twin-study”. Eur J Vasc Endovasc Surg 52: 41-46, 2016. DOI: 10.1016/j.ejvs.2016.03.012
  • Duvnjak S, Ravn P, Green A, Andersen PE: “Clinical Long-Term Outcome and Reinterventional Rate After Uterine Fibroid Embolization with Nonspherical Versus Spherical Polyvinyl Alcohol Particles”. Cardiovasc Intervent Radiol 39: 204-9, 2016. (Epub 30 June 2015). DOI 10.1007/s00270-015-1157-5
  • Green A, Pottegård A, Broe A, Diness TG, Emneus M, Hasvold P, Gislason GH: “Initiation and persistence with dual antiplatelet therapy after acute myocardial infarction – a Danish nationwide population-based cohort study”. Circulation: BMJ Open 6: e010880, 2016. (Epub 15. Maj 2016).  DOI: 10.1136/bmjopen-2015-010880
  • Sortsø C, Lauridsen J, Emneus M, Green A, Jensen PB. Decomposing Inequality in Diabetes Patients’ Morbidity Patterns, Survival and Health Care Usage in Denmark. COHERE – Centre of Health Economics Research, Discussion Papers. Department of Business and Economics, Faculty of Business and Social Sciences, University of Southen Denmark, 2016.
  • Kjærulff TM, Ersbøll AK, Green A, Emneus M, Pukkala E, Bolin K, Stavem K, Iversen P, Brasso K, Hallas J, Thygesen LC: “Patterns of finasteride use in the male populations of four Nordic countries: a cross-national drug utilization study”. Scand J Urol 50: 220-7, 2016.  (Epub 22 February 2016). DOI: 10.3109/21681805.2015.1136676
  • Green A, Sortsø C, Jensen PB, Emneus M: “Validation of the Danish National Diabetes Registry”. Clin Epidemiol 7: 5-15, 2015. DOI: 10.2147/CLEP.S72768
  • Iachina M, Green A, Møller H, Mellemgaard A, Krasnik M, Lüchtenborg M, Jakobsen E: “The effect of different comorbidities on survival of non-small cells lung cancer patients”. Lung 193: 91-297, 2015. (Epub Dec 14, 2014). DOI 10.1007/s00408-014-9675-5
  • Thomsen L, Lindholt J, Roeder O, Green A, Mikkelsen RT: “Excess mortality during the first year after arterial trauma”. Dan Med J 62(3): A5013, 2015
  • Bank S, Andersen PS, Burisch J, Pedersen N, Roug S, Galsgaard J, Turino SY Brodersen JB, Rashid S, Avlund S, Olesen TB, Green A, Hoffmann HJ, Thomsen MK, Thomsen VØ, Nexø BA, Vogel U, Andersen V: “Effectiveness of anti-tumour necrosis factor–α therapy in Danish patients with inflammatory bowel diseases”. Dan Med J 62(3): A4994, 2015
  • Mellemgaard A, Lüchtenburg M, Iachina M, Jakobsen E, Green A, Krasnik M, Møller H: “Role of comorbidity on survival after radio- and chemotherapy for non-surgically treated lung cancer”. J Thorac Oncol 10: 272-279, 2015 (Epub Nov3, 2014). DOI 10.1097/JTO.0000000000000416
  • Patterson CC, Gyürüs E, Rosenbauer J, Cinek O, Neu A, Schober E, Parslow RC, Joner G, Svensson J, Castell C, Bingley PJ, Schoenle E, Jarosz-Chobot P, Urbonaité B, Rothe U, Krzisnik C, Ionescu-Tirgoviste C, Weets I, Kocova M, Stipancic G, Samardzic M,  de Beaufort CE, Green A, Soltész G, Dahlquist GG: “Seasonal variation in month of diagnosis in children with type 1 diabetes registered in 23 European centres during 1989-2008: little short-term influence of sunshine hours or average temperature”. Pediatr Diabetes 16: 573-580, 2015. DOI 10.1111/pedi.12227
  • Sortsø C, Emneus M, Green A, Jensen PB, Eriksson T: “Societal costs of diabetes mellitus 2025 and 2040 – forecasts based on real world cost evidence and observed epidemiological trends in Denmark” Modern Economy 6: 1150-1166, 2015. DOI: 10.4236/me.2015.610109
  • Green A, Sortsø C, Jensen PB, Emneus: “Incidence, morbidity, mortality and prevalence of diabetes in Denmark, 2000-2011: results from the Diabetes Impact Study 2013”. Clin Epidemiol 7: 421-430, 2015. DOI: 10.2147/CLEP.S88577
  • Patterson CC, Gyürüs E, Rosenbauer J, Cinek O, Neu A, Schober E, Parslow RC, Joner G, Svensson J, Castell C, Bingley PJ, Schoenle E, Jarosz-Chobot P, Urbonaité B, Rothe U, Krzisnik C, Ionescu-Tirgoviste C, Weets I, Kocova M, Stipancic G, Samardzic M,  de Beaufort CE, Green A, Soltész G, Dahlquist GG: “Seasonal variation in month of diagnosis in children with type 1 diabetes registered in 23 European centres during 1989-2008: little short-term influence of sunshine hours or average temperature”. Pediatric Diabetes, 16(8): 573-580, 2015. DOI: 10.1111/pedi.12227 
  • Bolin K, Berggren F, Landtblom A-M. Prevalence and cost of epilepsy in Sweden – a register-based approach. Acta Neurologica Scandinavica. 2015 Jan;131(1):37–44. DOI: 10.1111/ane.12297.
  • Nielsen AA, Christensen H, Lund ED, Brandslund I, Christensen C, Green A: “Diabetes mortality differs between registers due to various disease definitions”.  Dan Med J. 2014; 61(5): A4840
  • Jørgensen TMM, Houlind K, Lindholdt JS, Green A: “Abdominal aortic diameter is increased in males with a family of abdominal aortic aneurysms: Results from the Danish VIVA-trial”. Eur Journal Vasc Endovasc 48:669-675, 2014, DOI: 10.1016/j.ejvs.2014.09.005
  • Techau M, Lunde A, Pedersen CG, Green A, Johanessen H, Nissen N: “Non-participants and reasons for non-participation in a pragmatic trial of energy healing as cancer rehabilitation”. Eur J Integr Med 6: 268-276, October 2014
  • PP Patterson CC, Gyürüs E, Rosenbauer J, Cinek O, Neu A, Schober E, Parslow RC, Joner G, Svensson J, Castell C, Bingley PJ, Schoenle E, Jarosz-Chobot P, Urbonaité B, Rothe U, Krzisnik C, Ionescu-Tirgoviste C, Weets I, Kocova M, Stipancic G, Samardzic M,  de Beaufort CE, Green A, Soltész G, Dahlquist GG: “Seasonal variation in month of diagnosis in children with type 1 diabetes registered in 23 European centres during 1989-2008: little short-term influence of sunshine hours or average temperature”. Pediatr Diabetes 10, October 2014. DOI 10.1111/pedi.12227
  • Green A, Emneus M, Iachina M, Stavem K, Bolin K, Pukkala E, McNally R, Busch-Sørensen M, Willenheimer R, Egstrup K, Kesäniemi A, Ray S, Pedersen T, Basta N, Kent C, Ramey DR: ”Incidence of cancer and mortality in patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial”. Amer J Cardiol 114: 1518-1522, 2014
  • Nielsen AA, Petersen PH, Green A, Christensen C, Christensen H, Brandslund I: “Changing from glucose to HbA1c for diabetes diagnosis: predictive values of one test and importance of analytical bias and imprecision”. Clin Chem Lab Med 52: 1069-1077, July 2014. DOI: 10.1515/cclm-2013-0337
  • Iachina M, Green A, Jakobsen E: “The direct and indirect impact of comorbidity on the survival of patients with non-small cell lung cancer: a combination of survival, staging and resection models with missing measurements in covariates”. BMJ  Open 4: e003846, Feb 12, 2014. DOI: 10.1136/bmjopen-2013-003846.
  • Bolin K, Berggren F, Landtblom A-M. Regional variation in prevalence and healthcare utilization due to epilepsy in Sweden. Acta Neurologica Scandinavica. 2014 Dec;130(6):354–9. DOI: 10.1111/ane.12274.
  • Brandt F, Thvilum M, Almind D, Christensen K, Green A, Hegedüs L, Brix TH: “Hyperthyroidism and psychiatric morbidity: evidence from a Danish nationwide register study”. Eur J Endocrinol 170: 341-348, 2013. doi: 10.1530/EJE-13-0708
  • Jakobsen E, Green A, Østerlind K, Riis T, Iachina M, Palshof T: “Nationwide quality improvement in lung cancer care: The role of the Danish Lung Cancer Group and Registry”. J Thorac Oncol 8: 1238-1247, 2013
  • Lindholt JS, Green A Søgaard R: “Screening for abdominalt aortaaneurysme i Danmark?”. Ugeskr Læger 179: 2170-2174, 2013 (in Danish)
  • Laursen JV, Hoffmann SS, Green A, Nybo M, Sjølie AK, Grauslund J: ”Associations between diabetic retinopathy and plasma levels of high-sensitive C-reactive protein or von Willebrand factor in long-term type 1 diabetic patients”. Curr Eye Res 38: 174-179, 2013. DOI: 10.3109/02713683.2012.713153
  • Brandt F, Thvilum M, Almind D, Christensen K, Green A, Hegedüs L, Brix TH: “Grave’s disease and toxic nodular goiter are both associated with increased mortality but differ with respect to the cause of death. A Danish population-based register study”. Thyroid 23: 408-413, 2013. Epub March 18, 2013. DOI: 10.1089/thy.2012.0500
  • Jørgensen JS, Jørgensen TMM, Green A, Sjølie AK, Grauslund J: “Long-term associations between serum lipids and panretinal photocoagulation in type 1 diabetes”. Current Eye Research 38: 889-893, 2013. Epub Apr 22, 2013. DOI: 10.3109/02713683.2013.786094
  • Gaedt Thorlund M, Borg Madsen M, Green A, Sjølie AK, Grauslund J: “Is smoking a risk factor for proliferative retinopathy in type 1 diabetes?” Ophthalmologica 230: 50-54, 2013. Epub Jun 7, 2013. DOI: 10.1159/000350813
  • Brandt F, Thvilum M, Almind D, Christensen K, Green A, Hegedüs L, Brix TH: “Morbidities before and after the diagnosis of hyperthyroidism. A nationwide register-based study”. Plos One, Epub June 20:8(6):e66711, 2013.   DOI: 10.1371/ journal.pone.0066711.
  • Ali S, Mealing S, Hawkins N, Lescrauwaet B, Bjork S,  Mantovani L, Lampertico P: “The use of individual patient level data (IPD) to quantify the impact of pre-treatment predictors of response to treatment in chronic hepatitis B patients”. BMJ Open, 3(1): e001309–e001309, 2013. DOI: 10.1136/bmjopen-2012-001309.
  • Kristian B, Wachtmeister K, Stefan F, Forsgren L. Retigabine as add-on treatment of refractory epilepsy – a cost-utility study in a Swedish setting. Acta Neurologica Scandinavica. 2013 Jun;127(6):419–26. DOI: 10.1111/ane.12077.
  • Laursen JV, Hoffmann SS, Green A, Nybo M, Sjølie AK, Grauslund J: ”Associations between diabetic retinopathy and plasma levels of high-sensitive C-reactive protein or von Willebrand factor in long-term type 1 diabetic patients”. Curr Eye Res 38: 174-179, 2013. Epub Aug 20, 2012. DOI: 10.3109/02713683.2012.713153
  • Brandt F, Almind D, Christensen K, Green A, Brix TH, Hegedüs L: “Excess mortality in hyperthyroidism: The influence of preexisting comorbidity and genetic confounding. A Danish nationwide register-based cohort study of twins and singletons”. J Clin Endocrinol Metab 97: 4123-4129, 2012. Epub: Aug 28, 2012. DOI: 10.1210/jc.2012-2268
  • Karlberg C, Falk C, Green A, Sjølie AK, Grauslund: “Proliferative retinopathy predicts nephropathy: a 25-year follow-up study of type 1 diabetic patients”. Acta Diabetol 49: 263-268, 2012
  • Kaerlev L, Iachina M, Pedersen JH, Green A, Nørgård BM: “CT-screening for lung cancer does not increase the use of anxiolytic or antidepressant medication”. BMC Cancer 12: 188, 2012 DOI: 10.1186/1471-2407-12-188
  • Brandt F, Almind D, Christensen K, Green A, Brix TH, Hegedüs L: “The influence of preexisting co-morbidity and genetic confounding. A Danish nation-wide register-based cohort study of twins and singletons”. J Clin Endocrinol Metab 2012. DOI: 10.1210/jc.2012-2268 (in press)
  • Patterson CC, Gyürüs E, Rosenbauer J, Cinek O, Neu A, Schober E, Parslow RC, Joner G, Svensson J, Castell C, Bingley PJ, Schoenle E, Jarosz-Chobot P, Urbonaité B, Rothe U, Krzisnik C, Ionescu-Tirgoviste C, Weets I, Kocova M, Stipancic G, Samardzic M, de Beaufort CE, Green A, Dahlquist G, Soltész G: “Trends in childhood type 1 diabetes incidence in Europe during 1989–2008: evidence of non-uniformity over time in rates of increase”. Diabetologia 55: 2142-2147, 2012
  • Jakobsen E, Green A, Østerlind K, Palshof T: “Dansk Lunge Cancer Register”. Ugeskr Læger 174: 2539, 2012 (in Danish)
  • Hansen S, Green A, Nielsen J, Haugaard M, Laursen R, Schultz H, Rasmussen B, Broholm H, Andersen P, Kosteljanetz M: “Dansk Neuro Onkologisk Register”. Ugeskr Læger 174: 2558, 2012 (in Danish)
  • Victoria Arama, Hakan Leblebicioglu, Krzysztof Simon, Jean Pierre Zarski, Claus Niederau, François Habersetzer, Johannes Vermehren, Wieslawa Bludzin, Mariana Jinga, Sercan Ulusoy, Isabelle Klauck, Edith Morais, Stefan Bjork, Benedicte Lescrauwaet, Driss Kamar, Stefan Zeuzem for the AI463-121 European Longitudinal Chronic Hepatitis B Study Group. The potential impact of healthcare reimbursement policies on the management of chronic hepatitis B: analysis of real-life data from five European countries (submitted to Antiviral Therapy 2012).
  • Victoria Arama, Hakan Leblebicioglu, Krzysztof Simon, Jean Pierre Zarski, Claus Niederau, François Habersetzer, Johannes Vermehren, Wieslawa Bludzin, Mariana Jinga, Sercan Ulusoy, Isabelle Klauck, Edith Morais, Stefan Bjork, Benedicte Lescrauwaet, Driss Kamar, Stefan Zeuzem for the AI463-121 European Longitudinal Chronic Hepatitis B Study Group. The potential impact of healthcare reimbursement policies on the management of chronic hepatitis B: analysis of real-life data from five European countries
  • Bram G. Verheggen, Chrissy Tan, Felix Gutiérrez, Josep M. Llibre, Stefan Bjork, Lourdes Betegón, Manuel Cotarelo, Benedicte Lescrauwaet. Assessing the cost-effectiveness of antiretroviral therapy in treatment-naïve HIV-1 infected patients in Spain: results of a microsimulation model (submitted to AIDS 2012)
  • Bram G Verheggen, Josep M Llibre, Eric Vandeloise, Maarten J Treur, Stefan Björk, Per-Olof Thuresson, Benedicte Lescrauwaet. Comparative efficacy, safety and tolerability of anti-retroviral regimens including efavirenz, ritonavir-boosted atazanavir, darunavir, or lopinavir in treatment-naïve HIV-1-infected adults: a systematic review of randomized clinical trials and Bayesian network meta-analysis (submitted to BMC Infec. Disease 2012)
  • Bram G Verheggen, Josep M Llibre, Eric Vandeloise, Maarten J Treur, Stefan Björk, P O Thuresson, Benedicte Lescrauwaet. A systematic review of randomized clinical trials and Bayesian network meta-analysis – (manuscript 2012)
  • Thuresson PO, Verheggen B, Lescrauwaet B, Tan C, Björk S. A novel HIV disease progression model: the need for a comprehensive assessment of long-term efficacy, resistance and treatment costs outcomes with ATV, DRV and LPV (manuscript 2012)
  • Green A, Kyvik KO: “Epidemiology – Disease, Treatment, Organization”. Pp. 33-43 in: Hilsted J, Borch-Johnsen K, Christiansen JS (eds): “Diabetes”. Second Edition, Munksgaard, Copenhagen, 2011 (in Danish)
  • Green A: “Danish clinical databases: An overview”. Scand J Publ Health 39 (Suppl 7): 68-71, 2011
  • Brandt F, Green A, Hegedüs L, Brix T: “A critical review and meta-analysis of the association between overt hyperthyroidism and mortality”. Eur J Endocrinol 165: 491-497, 2011
  • Emneus M: Ressourceperson ved ”Har vi råd til de små cancer sygdomme” Rare Focus, Magasinet om de sjældne former for cancer, 1/2011, side 17.
  • Ali S, Mealing S, Hawkins N, Lescrauwaet B, Bjork, S,  Mantovani L, Lampertico, P. The use of individual patient level data (IPD) to quantify the impact of pre-treatment predictors of response to treatment in chronic hepatitis B patients (submitted BMJ 2011)
  • Emneus M: Bidrag til ”Hvidbog om Fedmekirurgi: Fakta om Fedmekirurgi i Danmark 2010”, Sponsor : Covidien.
  • Laustrup H, Voss A, Green A, Junker P: “SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study”. Lupus 19: 239-246, 2010
  • Grauslund J, Green A, Kawasaki R, Hodgson L, Sjølie AK, Wong TY: “Retinal vascular fractals and microvascular and macrovascular complications in type 1 diabetes”. Ophthalmology 117: 1400-1405, 2010
  • Grauslund J, Rasmussen LM, Green A, Sjølie AK: “Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes? Scand J Clin Lab Invest, Scand J Clin Lab Invest. 70: 188-193, 2010
  • Grauslund J, Nybo M, Green A, Sjølie AK: “N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes”. Scand J Clin Lab Invest 70: 392-398, 2010
  • Bolin K, Berggren F, Forsgren L. Lacosamide as treatment of epileptic seizures – cost utility results for Sweden: Cost-utility of lacosamide. Acta Neurologica Scandinavica. 2010 Mar 1;121(6):406–12. DOI:10.1111/j.1600-0404.2010.01342.x.
  • Grauslund J, Jørgensen TM, Nybo M, Green A, Rasmussen LM, Sjølie AK: “Risk factors for mortality and ischaemic heart disease in patients with long-term type 1 diabetes”. J Diabetes Complications, 24: 223-228, 2010. (E-pub 2. juli. 2009, DOI: 10.1016/j.jdiacomp.2009.05.003)
  • Pontus Roos, Stefan Björk, Martha Emneus, Daniel Persson, Lisbeth Vang,  Estimation of latent losses in diabetes health using EQ-5D.  Abstract on Euro-Qol scientific meeting, Paris 3-4 September (2009)
  • Laustrup H, Voss A, Green A, Junker P: “Systemic lupus erythematosis. Occurrence in a Danish community. An 8-year prospective study”. Scand J Rheumatol 38: 128-132, 2009
  • Grauslund J, Green A, Sjølie AK: “Blindness in a 25-year follow-up of a population-based cohort of Danish type 1 diabetic patients”. Ophthalmology 116: 2170-2174, 2009
  • Patterson CC, Dahlquist G, Gyürüs E, Green A, Soltész G and the EURODIAB Study Group: “Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted numbers: possible doubling of new cases diagnosed under 5 years of age between 2005 and 2020?” The Lancet 373: 2027-2033, 2009
  • Grauslund J, Green A, Sjølie AK: “Prevalence and 25 year incidence of proliferative retinopathy among Danish type 1 diabetic patients”. Diabetologia 52: 1829-1835, 2009
  • Grauslund J, Hodgson L, Kawasaki R, Green A, Sjølie AK, Wong TY: “Retinal vessel calibre and micro- and macrovascular complications in type 1 diabetes”. Diabetologia 52: 2213-2217, 2009
  • Jørgensen TM, Grauslund J, Sjølie AK, Green A, Rasmussen LM, Nybo M: “Major diabetes-related events do not improve glycaemic regulation in a population-based cohort of type 1 diabetic individuals”. Scand J Clin Lab Invest 69: 748-751, 2009
  • Grauslund J, Green A, Sjølie AK: “Cataract surgery in a population-based cohort of patients with type 1 diabetes: long term incidence and risk factors. Acta Ophthalmologica, 2009, E-pub September 17, 2009. DOI: 10.1111/j.1755-3768.2009.01619.x
  • Michiel W van der Linden, MD PhD, Arian Plat MSc, Joelle A. Erkens PharmD PhD, Martha Emneus, Ron MC Herings, PhD,Large Impact of Antidiabetic Drug Treatment and hospitalisations on Economic Burden of Diabetes Mellitus iin the Netherlands during 2000 to 2004, article in the journal ‘Value in Health’ 2009, vol. 12, no6, pp. 909-914
  • Grauslund J, Green A, Sjølie AK: ”Proliferative retinopathy and proteinuria predict mortality in type 1 diabetic patients in Fyn County, Denmark”. Diabetologia 51: 583-588, 2008
  • Green A, Emneus M: “Diabetesepidemien i Danmark: Hvad foregår der og hvor skal vi hen?”. Tidsskrift for Dansk Sundhedsvæsen 7: 199-203, 2008 (in Danish)
  • Green A: ”Descriptive epidemiology of Type 1 diabetes in youth: Incidence, mortality, prevalence, and secular trends”. Endocrine Research 33: 1-15, 2008
  • Stochholm K, Laursen T, Green A, Laurberg P, Andersen M, Kristensen LO, Feldt-Rasmussen U, Christiansen JS, Frydenberg M, Gravholt CH: ”Morbidity and GH deficiency: a nationwide study”. Eur J Endocrinol 158: 447-457, 2008
  • Gopinath S, Ortqvist E, Norgren S, Green A, Sanjeevi CB: “Variations in incidence of type 1 diabetes in different municipalities of Stockholm”. Ann N Y Acad Sci 1150: 200-207, 2008
  • Kyvik KO, Green A: ”Genetic epidemiology of Type 1 diabetes mellitus”. Pp. 403-412 in: Ekoé J-M, Rewers M, Williams R, Zimmet P (eds): ”The epidemiology of diabetes mellitus”, 2nd edition. John Wiley & Sons; Chichester, 2008
  • Anders Green & Martha Emneus. Inviteret bidrag til Tidsskrift for Dansk Sundhedsvæsen, September 2008. Arbejdstitel: Diabetesepidemien i Danmark: Hvad foregår der og hvor skal vi hen?
  • Michiel W van der Linden, MD PhD, Arian W Plat MSc, Joelle A Erkens PharmD PhD, Martha Emneus, Ron MC Herings, PhD, Large Impact of Antidiabetic Drug Treatment and hospitalisations on Economic Burden of Diabetes Mellitus iin the Netherlands during 2000 to 2004, Poster, ISPOR 2008
  • Emneus M: Ressourceperson ved ”Antallet af diabetikere eksploderer”. Fokusmagasinet, maj 2008, side 6-8. Kan tilgås via www.fokusmagasinet.dk
  • Bolin K. Health among long-term survivors of breast cancer—an analysis of 5-year survivors based on the Swedish surveys of living conditions 1979–1995 and the Swedish Cancer Registry 2000. Psycho-Oncology. 2008 Jan;17(1):1–8. DOI:10.1002/pon.1189.
  • Kristensen JK, Drivsholm TB, Carstensen B, Steding-Jessen M, Green A: “Validering af metoder til identifikation af erkendt diabetes på basis af administrative sundhedsregistre”. Ugeskr. Læger 169: 1687-1692, 2007
  • Støvring H, Andersen M, Beck-Nielsen H, Green A, Vach W: ”Counting drugs to understand the disease: The case of measuring the diabetes epidemic”. Pop Health Metrics 5: 2, 2007 (DOI: 0.1186/1478-7954-5-2)
  • Stochholm K, Gravholt CH, Laursen T, Laurberg P, Andersen M, Kristensen LØ, Feldt-Rasmussen U, Christiansen JS, Frydenberg M, Green A: ”Mortality in growth hormon deficiency – a nationwide study”. Eur J Endocrinol 157: 9-18, 2007
  • Emneus M, Contributions to Diabetes barometer chapter 9, Indirect costs, 2007 Novo Nordisk, Danmark.
  • Emneus M, Contributions to “The hidden Burden”. A report on cost of diabetes in US, UK, India, China and Denmark, May 2007. The Economist Intelligence Unit. Storbrittanien.
  • Roos and M. Emneus. (2007). Analysis on the impact of NDP/DAWN activities on NN’s insulin sales volume. Scientific Report 2007:1, R.R. Institute of applied Economics, Malmö, Sverige.
  • Stochholm K, Gravholt CH, Laursen T, Jørgensen JO, Laurberg P, Andersen M, Kristensen LØ, Feldt-Rasmussen U, Christiansen JS, Frydenberg M, Green A: ”Incidence of growth hormone deficiency – a nationwide study”. Eur J Endocrinol 155: 61-71, 2006
  • S. Björk, M. Emneus, P. Roos and D. Persson. Relating Diabetes Health Status to Capability. 23rd Scientific Plenary meeting of the EuroQol Group. Health Economics and Outcome Research, Barcelona, Spanien (2006)
  • Emneus M, Changing the cost and benefits of diabetes; Who actually paying, Novo Nor­disk 2006
  • Green A, Rasmussen SR, Emneus M: “Sundhedsøkonomiske omkostninger og benefits ved behandling af diabetes mellitus i Danmark. Behandlerbladet 23, december 2006, side 6-11. Kan tilgås via www.diabetes.dk